Publicaciones en colaboración con investigadores/as de Hospital Universitario de la Princesa (23)

2023

  1. DNA Methylation Description of Hippocampus, Cortex, Amygdala, and Blood of Drug-Resistant Temporal Lobe Epilepsy

    Molecular Neurobiology, Vol. 60, Núm. 4, pp. 2070-2085

  2. Neuronal and astrocytic tetraploidy is increased in drug-resistant epilepsy

    Neuropathology and Applied Neurobiology, Vol. 49, Núm. 1

2022

  1. Pharmacogenetics of Donepezil and Memantine in Healthy Subjects

    Journal of Personalized Medicine, Vol. 12, Núm. 5

2021

  1. ABCB1 C3435T, G2677T/A and C1236T variants have no effect in eslicarbazepine pharmacokinetics

    Biomedicine and Pharmacotherapy, Vol. 142

  2. Benefits of the application of heat and pressure on peripheral venous cannulation in adults: A randomized controlled trial

    Journal of Advanced Nursing, Vol. 77, Núm. 3, pp. 1533-1545

  3. DNA copy number variation associated with anti-tumour necrosis factor drug response and paradoxical psoriasiform reactions in patients with moderate-to-severe psoriasis

    Acta Dermato-Venereologica

  4. Epigenetics in Non-tumor Immune-Mediated Skin Diseases

    Molecular Diagnosis and Therapy, Vol. 25, Núm. 2, pp. 137-161

  5. Growth arrest and DNA damage-inducible proteins (GADD45) in psoriasis

    Scientific Reports, Vol. 11, Núm. 1

  6. Intracellular calcium and inflammatory markers, mediated by purinergic stimulation, are differentially regulated in monocytes of patients with major depressive disorder

    Neuroscience Letters, Vol. 765

  7. Methylation in psoriasis. Does sex matter?

    Journal of the European Academy of Dermatology and Venereology

  8. Pharmacokinetic variability of eslicarbazepine in real clinical practice

    Epilepsy and Behavior, Vol. 124

2020

  1. Genome-wide association analysis of psoriasis patients treated with anti-TNF drugs

    Experimental Dermatology, Vol. 29, Núm. 12, pp. 1225-1232

  2. Pharmacogenetics update on biologic therapy in psoriasis

    Medicina (Lithuania), Vol. 56, Núm. 12, pp. 1-15

  3. Polymorphisms associated with optimization of biological therapy through drug dose reduction in moderate-to-severe psoriasis

    Journal of the European Academy of Dermatology and Venereology

2019

  1. Polymorphisms associated with anti-TNF drugs response in patients with psoriasis and psoriatic arthritis

    Journal of the European Academy of Dermatology and Venereology

2018

  1. Effect of Polymorphisms on the Pharmacokinetics, Pharmacodynamics and Safety of Sertraline in Healthy Volunteers

    Basic and Clinical Pharmacology and Toxicology, Vol. 122, Núm. 5, pp. 501-511

  2. Epigenetic biomarkers associated with antitumour necrosis factor drug response in moderate-to-severe psoriasis

    British Journal of Dermatology

  3. Histone modifications associated with biological drug response in moderate-to-severe psoriasis

    Experimental Dermatology, Vol. 27, Núm. 12, pp. 1361-1371

  4. How to make P-glycoprotein (ABCB1, MDR1) harbor mutations and measure its expression and activity in cell cultures?

    Pharmacogenomics, Vol. 19, Núm. 16, pp. 1285-1297

  5. Pharmacogenetics and Pharmacogenomics in Moderate-to-Severe Psoriasis

    American Journal of Clinical Dermatology, Vol. 19, Núm. 2, pp. 209-222